Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines were published in the past hour.
  • No new economic data releases or revisions arrived in the last hour.
  • No major geopolitical developments or conflict escalations were reported during the hour.
  • No central bank statements or policy actions occurred in the past hour.
  • No significant corporate earnings, M&A, or defaults were announced in the last hour.

Latest Articles

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
Aug 24, 2026
Nina Shah
Press Releases

Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851

Lexicon Pharmaceuticals has earned its third $10 million milestone payment in 2026 from Novo Nordisk following successful patient dosing in the Phase 1 trial of LX9851, a novel oral small molecule for obesity and metabolic disorders. This achievement brings total milestone payments to $75 million out of a potential $1 billion collaboration deal. Th…

LXRX
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval
Aug 24, 2026
Leila Farooq
Press Releases

BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval

BioCardia, a leader in cellular therapeutics for cardiovascular diseases, announced FDA confirmation of Pre-Submission Meeting minutes for its Helix Transendocardial Delivery Catheter. This ratification supports BioCardia's planned follow-on pre-submission intended to enable Helix's approval via the De Novo regulatory pathway, potentially accelerat…

BCDA
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
Aug 24, 2026
Ajmal Hussain
Press Releases

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026

Amarin Corporation plc announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2026 featuring new analyses from the REDUCE-IT trial and mechanistic EPA data. These presentations cover treatment adherence, long-term outcomes, and biomarker insights related to cardiovascular risk reduction with icosapent ethyl (VASCEPA/V…

AMRN
Generac: Early Signs of a Commercial Recovery — Tactical Long Setup
Aug 24, 2026
Avery Klein
Trade Ideas

Generac: Early Signs of a Commercial Recovery — Tactical Long Setup

Generac (GNRC) has shifted from a cyclical residential story toward commercial and industrial and data-center power solutions. Recent results and a large hyperscaler supply deal have reignited revenue growth and earnings beats. Valuation is not cheap, but improving fundamentals and supportive technicals set up a mid-term swing trade with defined ri…

GNRC
Optical Stocks Retrace After Big Gains - Is This a Buying Window?
Aug 24, 2026
Ajmal Hussain
Stock Markets

Optical Stocks Retrace After Big Gains - Is This a Buying Window?

The optical equipment group that outperformed earlier this year has reversed course sharply. Names including Coherent, Corning, Ciena and Lumentum have moved materially off their 52-week highs after hefty YTD gains driven by AI datacenter fiber demand. Technical indicators are bearish, fair value models still show premium valuations even after the …

Edible Garden and Square Roots Announce Strategic Partnership to Accelerate Farm-to-Formula® Functional Nutrition Platform
Aug 24, 2026
Marcus Reed
Press Releases

Edible Garden and Square Roots Announce Strategic Partnership to Accelerate Farm-to-Formula® Functional Nutrition Platform

Edible Garden AG, a Nasdaq-listed leader in controlled environment agriculture, announced a strategic partnership with Square Roots to develop a new generation of clean-label, functional ready-to-drink beverages. Combining Square Roots' expertise in plant science with Edible Garden's advanced Farm-to-Formula® platform and aseptic manufacturing, the…

EDBL
LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
Aug 24, 2026
Caleb Monroe
Press Releases

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

Biogen and Eisai announced US availability of LEQEMBI IQLIK®, a subcutaneous autoinjector for initiation and maintenance therapy of early Alzheimer's disease, offering a more convenient and flexible alternative to intravenous infusion. The treatment, supported by robust clinical trial data demonstrating slowed disease progression and significant co…

BIIB
Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Aug 24, 2026
Priya Menon
Press Releases

Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

Clearmind Medicine Inc., a clinical-stage biotech focused on psychedelic-derived neuroplastogens, announced the U.S. publication of a patent application covering a novel combination of MDMA and N-acylethanolamines such as PEA, aimed at treating PTSD, anxiety, and eating disorders. This comes alongside the FDA's newly finalized guidance for clinical…

CMND
Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
Aug 24, 2026
Ajmal Hussain
Press Releases

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Rhythm Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare has approved IMCIVREE® (setmelanotide) to treat patients with acquired hypothalamic obesity (HO), a rare disease characterized by significant weight gain due to hypothalamic injury. Supported by positive Phase 3 trial data, this marks IMCIVREE as the first approved…

RYTM
Evolution Metals & Technologies Corp. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes
Aug 24, 2026
Ajmal Hussain
Press Releases

Evolution Metals & Technologies Corp. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes

Evolution Metals & Technologies Corp. (Nasdaq: EMAT), a U.S.-based critical materials and manufacturing company, announced its preliminary inclusion in FTSE Russell's Russell 3000® and Russell 2000® indexes, effective September 21, 2026, pending final review. This inclusion is anticipated to increase the company's visibility among institutional and…

EMAT
ASML reports transactions under its current share buyback program
Aug 24, 2026
Priya Menon
Press Releases

ASML reports transactions under its current share buyback program

ASML Holding N.V., a global leader in semiconductor equipment manufacturing, has disclosed recent transactions under its ongoing share buyback program announced in January 2026. Over five consecutive days in August, ASML repurchased a total of approximately 252,684 shares at weighted average prices ranging from €1,506.98 to €1,618.13 per share. The…

ASML
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions
Aug 24, 2026
Avery Klein
Press Releases

Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

Humacyte, Inc. announced that following favorable discussions with the FDA, it intends to file a supplemental Biologics License Application (BLA) in November 2026 to expand approval of its acellular tissue engineered vessel (ATEV) for dialysis access. This follows FDA approval of ATEV for vascular trauma in 2024. The application will be supported b…

HUMA
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
Aug 24, 2026
Jordan Park
Press Releases

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

AEON Biopharma, listed on NYSE American as AEON, has named Paul Lee, M.D., Ph.D., former Deputy Director at the FDA's Office of Neuroscience, as acting Chief Regulatory Officer. Dr. Lee, who has been advising AEON on regulatory strategy via Clintrex Research LLC, will now lead the company’s interactions with the FDA and oversee the regulatory roadm…

AEON
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
Aug 24, 2026
Ajmal Hussain
Press Releases

Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma

Erasca, Inc. announced that the FDA has granted Fast Track Designation to its investigational drug ERAS-0015 for metastatic pancreatic adenocarcinoma. The designation is based on promising Phase 1 data demonstrating clinical activity and tolerability in multiple tumor types, including pancreatic and lung cancers. The company plans three potentially…

ERAS
TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards
Aug 24, 2026
Priya Menon
Press Releases

TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards

TTEC Holdings, Inc. has been awarded the Gold award in the 2026 Brandon Hall Group HCM Excellence Awards for their RealSkill AI-Driven Workforce Readiness program. The program uses AI-powered simulations and personalized coaching to help employees practice and improve customer interaction skills. This recognition highlights TTEC's leadership in app…

TTEC
Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners
Aug 24, 2026
Jordan Park
Press Releases

Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners

Datacentrex, Inc. has secured colocation capacity for deployment of more than 500 prepaid ElphaPex DG2 Scrypt ASIC miners, expected to be energized within 30 days. This expansion will increase the company's aggregate hashrate by approximately 21%, improving fleet energy efficiency without additional capital expenditure. The deployment aligns with i…

DTCX